ID: ALA4130226

Max Phase: Preclinical

Molecular Formula: C9H11ClN4S

Molecular Weight: 206.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.N#Cc1c(NC(=N)N)sc2c1CCC2

Standard InChI:  InChI=1S/C9H10N4S.ClH/c10-4-6-5-2-1-3-7(5)14-8(6)13-9(11)12;/h1-3H2,(H4,11,12,13);1H

Standard InChI Key:  XPAMCDVGCUOOKO-UHFFFAOYSA-N

Associated Targets(Human)

Adrenergic receptor alpha-2 812 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 206.27Molecular Weight (Monoisotopic): 206.0626AlogP: 1.41#Rotatable Bonds: 1
Polar Surface Area: 85.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.64CX LogP: 1.89CX LogD: 1.45
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.48Np Likeness Score: -2.33

References

1. Flood A, Trujillo C, Sanchez-Sanz G, Kelly B, Muguruza C, Callado LF, Rozas I..  (2017)  Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α2-Adrenoceptors.,  138  [PMID:28644987] [10.1016/j.ejmech.2017.06.008]

Source